Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Targeting the AhR pathway may help treat alopecia areata.

Candida antigen is an effective and promising treatment for alopecia areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Alarmin cytokines are key in controlling skin immunity and inflammation.

The FDA approved a new Pfizer drug for hair loss in teens.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Adalimumab can cause complete hair loss in rare cases.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

5ARI treatment improves hair growth in older men with minimal side effects.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Bexarotene gel shows promise as a new treatment for alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Off-label treatments are heavily used for alopecia areata due to limited approved options.